Načítá se...
Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
The retained functionality of the sodium iodide symporter (NIS) expressed in differentiated thyroid cancer (DTC) cells allows the further utilization of post-surgical radioactive iodine (RAI) therapy, which is an effective treatment for reducing the risk of recurrence, and even the mortality, of DTC...
Uloženo v:
| Vydáno v: | Endocrinol Metab (Seoul) |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Korean Endocrine Society
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6769341/ https://ncbi.nlm.nih.gov/pubmed/31565873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2019.34.3.215 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|